A Global prospective observation Al study of Real-world management of patients with atrial fibrillation at high risk of stroke (GARDENIA)

 
 
 

A Global prospective observation Al study of Real-world management of patients with atrial fibrillation at high risk of stroke (GARDENIA)

 

Status: Ongoing

Details

This type of research study is called a registry and is being done to learn more about immediate and long-term treatment and results in patients with Atrial Fibrillation, in order to determine best practices in the future.

 

Sponsor: Anthos Therapeutics, Inc.

IRB# 2022-143